Last week, the U.S. Congress failed to approve $15 billion needed to continue COVID-19 precautions, even though today’s low case counts are likely to rise, as they are in Europe, with the subvariant called BA.2.
We’ve learned that some expensive mitigation measures, such as deep cleaning, are a waste of money, and could be scrapped, but funding for studying COVID-19 should increase — not just for prevention measures and vaccines, but for research into the long-term consequences of infection.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
We humbly apologize for the inconvenience.